GSK-7975A

CAS No. 1253186-56-9

GSK-7975A( GSK-7975 | GSK7975 )

Catalog No. M11017 CAS No. 1253186-56-9

A selective CRAC channel blocker that inhibits store-operated Ca(2+) entry with IC50 of 3.4 uM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 87 Get Quote
10MG 140 Get Quote
25MG 302 Get Quote
50MG 488 Get Quote
100MG 696 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GSK-7975A
  • Note
    Research use only, not for human use.
  • Brief Description
    A selective CRAC channel blocker that inhibits store-operated Ca(2+) entry with IC50 of 3.4 uM.
  • Description
    A selective CRAC channel blocker that inhibits store-operated Ca(2+) entry with IC50 of 3.4 uM; shows little or no effect on the physiological Ca(2+) spiking evoked by acetylcholine or cholecystokinin; inhibits the release of mast cell mediators and T-cell cytokines from multiple human and rat preparations.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    GSK-7975 | GSK7975
  • Pathway
    GPCR/G Protein
  • Target
    Calcium Channel
  • Recptor
    Calcium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1253186-56-9
  • Formula Weight
    397.305
  • Molecular Formula
    C18H12F5N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 90 mg/mL 226.53 mM
  • SMILES
    O=C(NC1=NN(CC2=CC=C(O)C=C2C(F)(F)F)C=C1)C3=C(F)C=CC=C3F
  • Chemical Name
    2,6-difluoro-N-(1-(4-hydroxy-2-(trifluoromethyl)benzyl)-1H-pyrazol-3-yl)benzamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Gerasimenko JV, et al. Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):13186-91. 2. Rice LV, et al. Eur J Pharmacol. 2013 Mar 15;704(1-3):49-57. 3. Derler I, et al. Cell Calcium. 2013 Feb;53(2):139-51.
molnova catalog
related products
  • Ziconotide Acetate ...

    Ziconotide is an analgesic agent and has been used to treat neuropathic and non-neuropathic pain. Ziconotide acts by binding to N-type calcium channels situated on the terminal part of primary afferent neurons of the nociceptive pathway therefore reducing synaptic transmission with potent antinociceptive effects.

  • Coptisine sulfate

    Coptisine sulfate has growth inhibitory activity against human cancer cell line in the NCI's anticancer drug screening program.

  • Cinacalcet metabolit...

    Cinacalcet metabolite M4 is a metabolite of Cinacalcet. Cinacalcet is an allosteric agonist of Ca receptor.